These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. Herrmann R; Straub V; Blank M; Kutzick C; Franke N; Jacob EN; Lenard HG; Kröger S; Voit T Hum Mol Genet; 2000 Sep; 9(15):2335-40. PubMed ID: 11001938 [TBL] [Abstract][Full Text] [Related]
5. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Carbone I; Bruno C; Sotgia F; Bado M; Broda P; Masetti E; Panella A; Zara F; Bricarelli FD; Cordone G; Lisanti MP; Minetti C Neurology; 2000 Mar; 54(6):1373-6. PubMed ID: 10746614 [TBL] [Abstract][Full Text] [Related]
6. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes. Smythe GM; Eby JC; Disatnik MH; Rando TA J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260 [TBL] [Abstract][Full Text] [Related]
7. Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro. Traverso M; Gazzerro E; Assereto S; Sotgia F; Biancheri R; Stringara S; Giberti L; Pedemonte M; Wang X; Scapolan S; Pasquini E; Donati MA; Zara F; Lisanti MP; Bruno C; Minetti C Lab Invest; 2008 Mar; 88(3):275-83. PubMed ID: 18253147 [TBL] [Abstract][Full Text] [Related]
8. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency. Minetti C; Bado M; Broda P; Sotgia F; Bruno C; Galbiati F; Volonte D; Lucania G; Pavan A; Bonilla E; Lisanti MP; Cordone G Am J Pathol; 2002 Jan; 160(1):265-70. PubMed ID: 11786420 [TBL] [Abstract][Full Text] [Related]
9. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. Repetto S; Bado M; Broda P; Lucania G; Masetti E; Sotgia F; Carbone I; Pavan A; Bonilla E; Cordone G; Lisanti MP; Minetti C Biochem Biophys Res Commun; 1999 Aug; 261(3):547-50. PubMed ID: 10441463 [TBL] [Abstract][Full Text] [Related]
10. A CAV3 microdeletion differentially affects skeletal muscle and myocardium. Cagliani R; Bresolin N; Prelle A; Gallanti A; Fortunato F; Sironi M; Ciscato P; Fagiolari G; Bonato S; Galbiati S; Corti S; Lamperti C; Moggio M; Comi GP Neurology; 2003 Dec; 61(11):1513-9. PubMed ID: 14663034 [TBL] [Abstract][Full Text] [Related]
11. Caveolin-3 in muscular dystrophy. McNally EM; de Sá Moreira E; Duggan DJ; Bönnemann CG; Lisanti MP; Lidov HG; Vainzof M; Passos-Bueno MR; Hoffman EP; Zatz M; Kunkel LM Hum Mol Genet; 1998 May; 7(5):871-7. PubMed ID: 9536092 [TBL] [Abstract][Full Text] [Related]
12. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Matsuda C; Hayashi YK; Ogawa M; Aoki M; Murayama K; Nishino I; Nonaka I; Arahata K; Brown RH Hum Mol Genet; 2001 Aug; 10(17):1761-6. PubMed ID: 11532985 [TBL] [Abstract][Full Text] [Related]
13. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Muchir A; Bonne G; van der Kooi AJ; van Meegen M; Baas F; Bolhuis PA; de Visser M; Schwartz K Hum Mol Genet; 2000 May; 9(9):1453-9. PubMed ID: 10814726 [TBL] [Abstract][Full Text] [Related]
14. Limb-girdle muscular dystrophy in a 71-year-old woman with an R27Q mutation in the CAV3 gene. Figarella-Branger D; Pouget J; Bernard R; Krahn M; Fernandez C; Lévy N; Pellissier JF Neurology; 2003 Aug; 61(4):562-4. PubMed ID: 12939441 [TBL] [Abstract][Full Text] [Related]
15. Genetic localization of a newly recognized autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-21. van der Kooi AJ; van Meegen M; Ledderhof TM; McNally EM; de Visser M; Bolhuis PA Am J Hum Genet; 1997 Apr; 60(4):891-5. PubMed ID: 9106535 [TBL] [Abstract][Full Text] [Related]
17. Consequences of a novel caveolin-3 mutation in a large German family. Fischer D; Schroers A; Blümcke I; Urbach H; Zerres K; Mortier W; Vorgerd M; Schröder R Ann Neurol; 2003 Feb; 53(2):233-41. PubMed ID: 12557291 [TBL] [Abstract][Full Text] [Related]
18. Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3. Galbiati F; Volonte D; Minetti C; Bregman DB; Lisanti MP J Biol Chem; 2000 Dec; 275(48):37702-11. PubMed ID: 10973975 [TBL] [Abstract][Full Text] [Related]